Home ›
Organizations ›
WASHINGTON INSTITUTE FOR COAGULATION
WASHINGTON INSTITUTE FOR COAGULATION
WA · Disease Research · EIN 832302258
12
Executives Disclosed
$122.5M
Annual Revenue
$78.7M
Total Assets
2:1
Internal Pay Ratio
WASHINGTON INSTITUTE FOR COAGULATION has 12 executives with disclosed compensation. The highest-paid executive, Rebecca Kruse-Jarres Md (EXECUTIVE/MEDICAL DIRECTOR), received peak total compensation of $397,677. The sector average for Disease Research executives is $215K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Rebecca Kruse-Jarres Md | EXECUTIVE/MEDICAL DIRECTOR | $398K | $367K | 2020–2023 | 5.3x |
| Nicole Jobson | OPERATIONS DIRECTOR | $183K | $183K | 2021–2023 | 2.4x |
| Heebeen Kim | CLINICAL PHARMACIST | $164K | $164K | 2023–2023 | 2.2x |
| Anne Jezzamine Choi | NURSE PRACTITIONER | $150K | $0 | 2023–2023 | 2x |
| John Sokol | PHARMACY DIRECTOR | $149K | $0 | 2021–2021 | 2x |
| Renee Killian | CLINIC NURSE COORDINATOR | $143K | $0 | 2023–2023 | 1.9x |
| Bruno Steiner | PHYSICAL THERAPY & MSKUS PROGRAM MGR | $141K | $0 | 2023–2023 | 1.9x |
| Catlin Goodfriend | CLINICAL PHARMACIST | $141K | $0 | 2023–2023 | 1.9x |
| Jennifer Lamharzi | NURSE COORDINATOR | $139K | $0 | 2021–2021 | 1.9x |
| Barbara Konkle Md | RESEARCH DIRECTOR | $139K | $0 | 2021–2021 | 1.9x |
| Jezzamine Choi | CLINICAL NURSE PRACTITIONER | $129K | $0 | 2021–2021 | 1.7x |
| Kim Snyder | CHIEF FINANCIAL OFFICER/COO | $29K | $0 | 2023–2023 | 0.4x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2020 | 1 | $30K | $30K | $30K |
| 2021 | 6 | $280K | $398K | $560K |
| 2023 | 8 | $238K | $367K | $714K |
Email Alerts
Get notified about WASHINGTON INSTITUTE FOR COAGULATION
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.